PLRX financial statements and SEC filings
PLRX annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $0.00 | -$156.37M | -$149.34M | 10-K |
| 2024-12-31 | $0.00 | -$228.37M | -$210.30M | 10-K |
| 2023-12-31 | $1.58M | -$184.15M | -$161.34M | 10-K |
| 2022-12-31 | $9.69M | -$127.20M | -$123.32M | 10-K |
| 2021-12-31 | $7.57M | -$97.53M | -$97.26M | 10-K |
| 2020-12-31 | $41.82M | -$41.65M | -$41.53M | 10-K |
PLRX annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $225.23M | $44.02M | $181.21M | 10-Q |
| 2024-12-31 | $396.95M | $92.87M | $304.08M | 10-K |
| 2023-12-31 | $512.15M | $38.58M | $473.58M | 10-K |
| 2022-12-31 | $350.61M | $37.27M | $313.34M | 10-K |
| 2021-12-31 | $221.22M | $22.16M | $199.06M | 10-K |
| 2020-12-31 | $295.53M | $12.46M | $283.06M | 10-K |
PLRX annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$128.34M | -$374.00K | -$31.70M | 10-K |
| 2024-12-31 | -$155.50M | -$3.85M | $23.12M | 10-K |
| 2023-12-31 | -$116.36M | -$921.00K | $274.40M | 10-K |
| 2022-12-31 | -$94.63M | -$1.76M | $226.85M | 10-K |
| 2021-12-31 | -$75.44M | -$1.95M | $2.53M | 10-K |
| 2020-12-31 | -$37.27M | -$1.53M | $213.21M | 10-K |